GENERAL COUNSEL & CORP SEC · Stoke Therapeutics, Inc. · Common Stock
Side
SELL
Value
$21K
Shares
601
Price
$34.41
Executed
Mar 20, 2026
Disclosed
Mar 24, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Mar 20 executedMar 24, 2026 disclosed
STOK · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+1 / 15
Routine: 16 prior trades recorded in this security
Frequency & clustering+15 / 15
3 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Allan Jonathan filed this Form 4 reporting a open-market sale of STOK on Mar 20, 2026. It became public on Mar 24, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
GENERAL COUNSEL & CORP SEC
Allan Jonathancik:0001966716
Issuer
Stoke Therapeutics, Inc.cik:0001623526
Revision history · 0
No field has changed since this record was first ingested.
